MELFALAX 2MG TABLET

About

Melfalax 2mg Tablet contains melphalan, an oral alkylating agent used in the treatment of various cancers. As a nitrogen mustard derivative, it exerts its cytotoxic effects by forming covalent bonds with DNA, leading to cross-linking of DNA strands. This process inhibits DNA replication and RNA synthesis, ultimately disrupting cell division and inducing apoptosis in rapidly proliferating cancer cells.

The oral formulation provides a convenient option for long-term maintenance therapy or for patients where intravenous administration is not feasible. It is particularly utilized in conditions such as multiple myeloma and certain types of ovarian cancer. Due to its potent myelosuppressive properties, regular monitoring of hematologic parameters is crucial throughout the treatment course.

Uses

• Treatment of multiple myeloma
• Management of ovarian carcinoma
• Palliative treatment of breast cancer
• Adjuvant therapy in certain solid tumors

Directions For Use

Take orally on an empty stomach, at least one hour before or two hours after meals, as directed by your oncologist.

Benefits

• Oral administration for convenience
• Effective against various cancers
• Can be used for maintenance therapy
• Targets rapidly dividing cancer cells
• Established efficacy in multiple myeloma
• Alternative to intravenous administration

Side Effects

• Bone marrow suppression (anemia, leukopenia, thrombocytopenia)
• Nausea and vomiting
• Oral mucositis
• Diarrhea
• Hair loss (alopecia)
• Skin rash
• Fever
• Fatigue
• Liver enzyme elevation
• Pulmonary fibrosis (rare)
• Secondary malignancies (long-term risk)
• Infertility

Safety Measures

• Alcohol - Avoid alcohol consumption as it may worsen gastrointestinal side effects and potentially increase liver toxicity.
• Pregnancy - Highly teratogenic and embryotoxic. Absolutely contraindicated during pregnancy due to severe risk of fetal harm or death.
• Breastfeeding - Contraindicated during breastfeeding due to the potential for serious adverse effects on the infant.
• Liver - Use with extreme caution in patients with hepatic impairment. Dosage adjustments may be necessary, and liver function should be closely monitored.
• Kidney - Dosage reduction is often required in patients with renal impairment due to decreased drug clearance. Close monitoring of kidney function is essential.
• Lung - Use with caution in patients with pre-existing lung conditions, as pulmonary toxicity (e.g., interstitial pneumonitis, fibrosis) can occur, though rare.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.